JPRN-UMIN000001547已完成未知
Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer - Clinical Investigation of Bevacizumab plus FOLFIRI or FOLFOX in previously treated metastatic colorectal cancer (2nd-BV)
Tsukuba Cancer Clinical Trial Group0 个研究点目标入组 400 人开始时间: 2008年12月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Prior bevacizumab administration 2)FOLFIRI+bevacizumab in patients with previous CPT-11-based chemotherapy, or FOLFOX+bevacizumab in patients with previous L-OHP-based chemotherapy
研究者
相似试验
已完成
不适用
Effect of Sitopaladi Churna in the treatment of Kasa (Stable chronic Bronchitis)CTRI/2017/10/010253Central Council For Research in Ayurvedic Sciences67
已完成
不适用
Exploratory study for the efficacy and safety of Sansoninto on behavioral and psychological symptoms of dementia (BPSD) in patients with Dementia.: Multicenter trialDementia patients with BPSDJPRN-UMIN000021562Kanazawa University20
已完成
不适用
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastasesJPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
未知
2 期
Investigation of the efficacy/safety and clinical dose of TAK-390MR for Erosive Esophagitis - A Phase II/III, Stratified-Randomized, Double-Blind, Parallel-Group, Multicenter Study on Efficacy and Safety of TAK-390MR by Comparison with AG-1749 in Patients with Erosive EsophagitisSubjects endoscopically diagnosed erosive esophagitisJPRN-jRCT2080220529Takeda Pharmaceutical Company Limited850
已完成
不适用
Investigation for clinical efficacy and safety of ipragliflozin 50mg and 100mg on type 2 diabetesType 2 diabetesJPRN-UMIN000016131Osaka Saiseikai Nakatsu Hospital Division of diabetes and endocrinology600